Dose Response Trial of Pergolide for Cocaine Dependence - 1

This study has been completed.
Information provided by:
Medical University of South Carolina Identifier:
First received: September 20, 1999
Last updated: September 11, 2012
Last verified: May 1997

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Condition Intervention Phase
Cocaine-Related Disorders
Drug: Pergolide
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Dose Response Trial of Pergolide for Cocaine Dependence

Resource links provided by NLM:

Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Side effects
  • Drug use
  • Retention
  • Cocaine withdrawal
  • Compliance
  • Effectiveness of medication for global improvements

Estimated Enrollment: 0
Study Start Date: February 1996

Ages Eligible for Study:   21 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Please contact site for information.

  Contacts and Locations
Please refer to this study by its identifier: NCT00000248

United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742
Sponsors and Collaborators
Medical University of South Carolina
Principal Investigator: Robert Malcolm, M.D. Medical University of South Carolina
  More Information

No publications provided Identifier: NCT00000248     History of Changes
Other Study ID Numbers: NIDA-08355-1, R01DA008355, R01-08355-1
Study First Received: September 20, 1999
Last Updated: September 11, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Dopamine Agonists
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs processed this record on April 23, 2014